Sanofi Impairment Loss Recognised In Profit Or Loss Goodwill
Sanofi (SNY) reported Impairment Loss Recognised In Profit Or Loss Goodwill of EUR 0 for the 12-month period ending 2025-12-31, per its 20-F filed 2026-02-17.
Financial Statements › Expense Statement › Operating Expenses
ifrs-full:ImpairmentLossRecognisedInProfitOrLossGoodwill · last filed 2026-02-17
| Period end | Impairment Loss Recognised In Profit Or Loss Goodwill 12 month |
|---|---|
| 2025-12-31 | 0.00 EUR 20-F · filed 2026-02-17 |
| 2024-12-31 | 0.00 EUR 20-F · filed 2026-02-17 |
| 2023-12-31 | 0.00 EUR 20-F · filed 2026-02-17 |
| 2022-12-31 | 0.00 EUR 20-F · filed 2025-02-13 |
| 2021-12-31 | 0.00 EUR 20-F · filed 2024-02-23 |
| 2020-12-31 | 0.00 EUR 20-F · filed 2023-02-24 |
| 2019-12-31 | 0.00 EUR 20-F · filed 2022-02-23 |
| 2018-12-31 | 0.00 EUR 20-F · filed 2021-03-04 |
| 2017-12-31 | 0.00 EUR 20-F · filed 2020-03-05 |